Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Colorectal Carcinoma
|
1962 | 0.672 | 0.360 | 1 | 45331833 | missense variant | C/A;G | snv | 0.29 | 0.27 | 0.060 | 0.833 | 6 | 2008 | 2018 | ||||
Age related macular degeneration
|
663 | 0.672 | 0.360 | 1 | 45331833 | missense variant | C/A;G | snv | 0.29 | 0.27 | 0.020 | 1.000 | 2 | 2012 | 2012 | ||||
Carcinoma of lung
|
1204 | 0.672 | 0.360 | 1 | 45331833 | missense variant | C/A;G | snv | 0.29 | 0.27 | 0.020 | 1.000 | 2 | 2004 | 2009 | ||||
Glaucoma, Primary Open Angle
|
222 | 0.672 | 0.360 | 1 | 45331833 | missense variant | C/A;G | snv | 0.29 | 0.27 | 0.020 | 1.000 | 2 | 2013 | 2015 | ||||
Malignant neoplasm of lung
|
1142 | 0.672 | 0.360 | 1 | 45331833 | missense variant | C/A;G | snv | 0.29 | 0.27 | 0.020 | 1.000 | 2 | 2004 | 2009 | ||||
Primary malignant neoplasm of lung
|
981 | 0.672 | 0.360 | 1 | 45331833 | missense variant | C/A;G | snv | 0.29 | 0.27 | 0.020 | 1.000 | 2 | 2004 | 2009 | ||||
Adenomatous Polyps
|
20 | 0.672 | 0.360 | 1 | 45331833 | missense variant | C/A;G | snv | 0.29 | 0.27 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Breast Carcinoma
|
2793 | 0.672 | 0.360 | 1 | 45331833 | missense variant | C/A;G | snv | 0.29 | 0.27 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Cervical Squamous Cell Carcinoma
|
44 | 0.672 | 0.360 | 1 | 45331833 | missense variant | C/A;G | snv | 0.29 | 0.27 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Cervix carcinoma
|
283 | 0.672 | 0.360 | 1 | 45331833 | missense variant | C/A;G | snv | 0.29 | 0.27 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Colon Carcinoma
|
275 | 0.672 | 0.360 | 1 | 45331833 | missense variant | C/A;G | snv | 0.29 | 0.27 | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||
Human papilloma virus infection
|
42 | 0.672 | 0.360 | 1 | 45331833 | missense variant | C/A;G | snv | 0.29 | 0.27 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Impaired cognition
|
348 | 0.672 | 0.360 | 1 | 45331833 | missense variant | C/A;G | snv | 0.29 | 0.27 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Malignant neoplasm of breast
|
3417 | 0.672 | 0.360 | 1 | 45331833 | missense variant | C/A;G | snv | 0.29 | 0.27 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Malignant neoplasm of colon and/or rectum
|
502 | 0.672 | 0.360 | 1 | 45331833 | missense variant | C/A;G | snv | 0.29 | 0.27 | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||
Malignant neoplasm of thyroid
|
103 | 0.672 | 0.360 | 1 | 45331833 | missense variant | C/A;G | snv | 0.29 | 0.27 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Malignant Neoplasms
|
1641 | 0.672 | 0.360 | 1 | 45331833 | missense variant | C/A;G | snv | 0.29 | 0.27 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Malignant tumor of colon
|
688 | 0.672 | 0.360 | 1 | 45331833 | missense variant | C/A;G | snv | 0.29 | 0.27 | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||
Mental deterioration
|
121 | 0.672 | 0.360 | 1 | 45331833 | missense variant | C/A;G | snv | 0.29 | 0.27 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Non-Small Cell Lung Carcinoma
|
712 | 0.672 | 0.360 | 1 | 45331833 | missense variant | C/A;G | snv | 0.29 | 0.27 | 0.010 | 1.000 | 1 | 2015 | 2015 | ||||
Primary malignant neoplasm
|
1374 | 0.672 | 0.360 | 1 | 45331833 | missense variant | C/A;G | snv | 0.29 | 0.27 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Rectal Carcinoma
|
112 | 0.672 | 0.360 | 1 | 45331833 | missense variant | C/A;G | snv | 0.29 | 0.27 | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||
Thyroid carcinoma
|
145 | 0.672 | 0.360 | 1 | 45331833 | missense variant | C/A;G | snv | 0.29 | 0.27 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Thyroid Neoplasm
|
135 | 0.672 | 0.360 | 1 | 45331833 | missense variant | C/A;G | snv | 0.29 | 0.27 | 0.010 | 1.000 | 1 | 2012 | 2012 |